Literature DB >> 8051739

Interleukin-6 and interstitial cystitis.

M Lotz1, P Villiger, T Hugli, J Koziol, B L Zuraw.   

Abstract

We analyzed the presence of the cytokine interleukin-6 in urine samples from interstitial cystitis patients. Interleukin-6 was significantly elevated in patients with interstitial cystitis (169.29 +/- 90.81 pg./ml. versus 34.8 +/- 6.35 pg./ml. in controls). Representative urine samples were analyzed with specific antibody to interleukin-6 and greater than 80% of the biological activity was neutralized. These cytokine measurements were then compared with clinical parameters and interleukin-6 levels correlated positively with the pain scores. Studies on the potential cellular origin of interleukin-6 showed increased levels in spontaneously voided urine but not in ureteral urine, which was collected during cystoscopy, suggesting that interleukin-6 is the product of activated cells in the bladder. This finding is supported by in situ hybridization analyses, which showed that interleukin-6 messenger ribonucleic acid expressing cells are located in the interstitium and epithelial layer, and within blood vessels. The implications of these findings for interstitial cystitis pathogenesis are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8051739     DOI: 10.1016/s0022-5347(17)32594-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  25 in total

1.  Tumor necrosis factor-α induces expression and release of interleukin-6 by human urothelial cells.

Authors:  Zun-Yi Wang; Dale E Bjorling
Journal:  Inflamm Res       Date:  2010-12-30       Impact factor: 4.575

Review 2.  Interstitial cystitis.

Authors:  D R Erickson; M F Davies
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1998

Review 3.  Detection of inflammatory biomarkers in saliva and urine: Potential in diagnosis, prevention, and treatment for chronic diseases.

Authors:  Sahdeo Prasad; Amit K Tyagi; Bharat B Aggarwal
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-24

4.  Is there a relation between urinary interleukin-6 levels and symptoms before and after intra-vesical glycosaminoglycan substitution therapy in patients with bladder pain syndrome/interstitial cystitis?

Authors:  Lukas K Daha; Dara Lazar; Reiner Simak; Heinz Pflüger
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-03-20

5.  Intravesical dimethyl sulfoxide inhibits acute and chronic bladder inflammation in transgenic experimental autoimmune cystitis models.

Authors:  Ronald Kim; Wujiang Liu; Xiaohong Chen; Karl J Kreder; Yi Luo
Journal:  J Biomed Biotechnol       Date:  2010-11-11

Review 6.  Treatment approaches for painful bladder syndrome/interstitial cystitis.

Authors:  Theoharis C Theoharides
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Multiplex analysis of urinary cytokine levels in rat model of cyclophosphamide-induced cystitis.

Authors:  Marc C Smaldone; Yoram Vodovotz; Vikas Tyagi; Derek Barclay; Brian J Philips; Naoki Yoshimura; Michael B Chancellor; Pradeep Tyagi
Journal:  Urology       Date:  2008-10-09       Impact factor: 2.649

8.  Urinary bladder hypersensitivity and dysfunction in female mice following early life and adult stress.

Authors:  Angela N Pierce; Elizabeth R Di Silvestro; Olivia C Eller; Ruipeng Wang; Janelle M Ryals; Julie A Christianson
Journal:  Brain Res       Date:  2016-03-02       Impact factor: 3.252

Review 9.  Influence of polyunsaturated fatty acids on urologic inflammation.

Authors:  Seetha M Tamma; Barbara Shorter; Khai-Lee Toh; Robert Moldwin; Barbara Gordon
Journal:  Int Urol Nephrol       Date:  2015-09-28       Impact factor: 2.370

10.  Uropathogenic Escherichia coli-induced inflammation alters mouse urinary bladder contraction via an interleukin-6-activated inducible nitric oxide synthase-related pathway.

Authors:  Te I Weng; Hsiao Yi Wu; Pei Ying Lin; Shing Hwa Liu
Journal:  Infect Immun       Date:  2009-05-26       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.